---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-041044"
form_type: "8-K"
ticker: "BFRG"
cik: "0001829247"
company_name: "BullFrog AI Holdings, Inc."
filed_at: "2024-10-15T23:59:59+00:00"
generated_at: "2026-05-30T14:42:02.860464+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Bullfrog AI appoints GSK veteran Dr. John Baldoni to Scientific Advisory Board

## Summary
- Dr. Baldoni brings 40+ years of pharma experience, including 29 years at GSK as SVP of Platform and Technology Sciences.
- He contributed to scores of commercial products and co-founded the ATOM consortium for AI-driven drug development.
- CEO Vin Singh cited Baldoni's insights as key to guiding commercialization of the bfLEAP platform.

## SEC filing metadata
- accession: 0001493152-24-041044
- form_type: 8-K
- ticker: BFRG
- cik: 0001829247
- company_name: BullFrog AI Holdings, Inc.
- filed_at: 2024-10-15T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1829247/000149315224041044/0001493152-24-041044-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1829247/000149315224041044/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-041044
- JSON: https://secwatch.observer/filing/0001493152-24-041044.json
- Plain text: https://secwatch.observer/filing/0001493152-24-041044.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.